The estimated Net Worth of Katherine B Quinn is at least $1.78 million dollars as of 18 May 2021. Ms. Quinn owns over 25,000 units of Rite Aid stock worth over $54,861 and over the last 10 years she sold RAD stock worth over $1,536,750. In addition, she makes $192,466 as Independent Director at Rite Aid.
Sign up
Ms. Quinn RAD stock SEC Form 4 insiders trading
Katherine has made over 3 trades of the Rite Aid stock since 2015, according to the Form 4 filled with the SEC. Most recently she sold 25,000 units of RAD stock worth $1,536,750 on 18 May 2021.
The largest trade she's ever made was selling 25,000 units of Rite Aid stock on 18 May 2021 worth over $1,536,750. On average, Katherine trades about 674 units every 53 days since 2015. As of 18 May 2021 she still owns at least 84,401 units of Rite Aid stock.
You can see the complete history of Ms. Quinn stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Katherine Quinn biography
Katherine Quinn serves as Independent Director of the Company. Ms. Quinn has served as vice chairman and chief administrative officer of U.S. Bancorp since April 2017 and is responsible for leading human resources, strategy and corporate affairs at the company. Quinn joined U.S. Bancorp in 2013 as executive vice president and chief strategy and reputation officer. Prior to joining U.S. Bancorp, Quinn most recently served as senior vice president and chief marketing officer at Anthem, a health benefits company, where she directed the company’s marketing, customer communications, digital, customer experience and retail strategies. She previously served as Anthem’s vice president of corporate marketing. Earlier in her career, Quinn served as chief marketing and strategy officer at a division of The Hartford, following leadership roles in strategy and product development at CIGNA and PacifiCare Health Systems, respectively. Quinn earned an MBA from University of Phoenix and a bachelor’s degree from Hunter College. In addition to her role at U.S. Bancorp, Quinn presently serves as a member of the Board of Trustees for both Minnesota Public Radio, and Fraser, a non-profit organization serving children and adults with special needs.
What is the salary of Katherine Quinn?
As the Independent Director of Rite Aid, the total compensation of Katherine Quinn at Rite Aid is $192,466. There are 16 executives at Rite Aid getting paid more, with Heyward Donigan having the highest compensation of $8,619,340.
How old is Katherine Quinn?
Katherine Quinn is 54, she's been the Independent Director of Rite Aid since 2019. There are 11 older and 7 younger executives at Rite Aid. The oldest executive at Rite Aid Corp. is Arun Nayar, 69, who is the Independent Director.
What's Katherine Quinn's mailing address?
Katherine's mailing address filed with the SEC is Nicollet Mall, Loring Park, Minneapolis, Hennepin County, Minnesota, 55402, United States.
Insiders trading at Rite Aid
Over the last 45 years, insiders at Rite Aid have traded over $704,219,544 worth of Rite Aid stock and bought 1,989,612 units worth $9,286,101 . The most active insiders traders include Coutu Group (Pjc) Inc. Jean, John M Baumer et Equity Investors Iii Lpgei .... On average, Rite Aid executives and independent directors trade stock every 238 days with the average trade being worth of $2,811,488. The most recent stock trade was executed by Heyward R Donigan on 22 December 2021, trading 14,350 units of RAD stock currently worth $199,896.
What does Rite Aid do?
riteaid is a company based out of 7189 henry clay blvd, liverpool, new york, united states.
What does Rite Aid's logo look like?
Complete history of Ms. Quinn stock trades at Ontrak Inc, Rite Aid, Tyson Foods et U.S. Bancorp
Rite Aid executives and stock owners
Rite Aid executives and other stock owners filed with the SEC include:
-
Heyward Donigan,
President, Chief Executive Officer, Director -
Heyward Rutledge Donigan B.A.,
Pres CEO & Director -
Jocelyn Konrad,
Executive Vice President - Pharmacy and Retail Operations -
Matthew Schroeder,
Chief Financial Officer, Senior Vice President -
James Peters,
Chief Operating Officer -
Jocelyn Zazyczny Konrad,
Exec. VP & Chief Pharmacy Officer -
James Joseph Peters Jr.,
Chief Operating Officer -
Matthew C. Schroeder,
CFO & Exec. VP -
Justin L. Mennen,
Exec. VP & Chief Information Officer -
Bruce Bodaken,
Independent Chairman of the Board -
Louis Miramontes,
Independent Director -
Arun Nayar,
Independent Director -
Kevin Lofton,
Independent Director -
Robert Knowling,
Independent Director -
Marcy Syms,
Independent Director -
Elizabeth Burr,
Independent Director -
Katherine Quinn,
Independent Director -
Bari Harlam,
Independent Director -
Paul Gilbert,
General Counsel, Company Secretary -
Brian Hoover,
Chief Accounting Officer -
Roxanne Schwans,
Senior Vice President - Market Access and Pharmacy Purchasing -
Angele Robinson-Gaylord,
Senior Vice President - Store Development -
Chris Bohrer,
Senior Vice President - Payor and Strategic Initiatives -
Trent Kruse,
Senior Vice President of Investor Relations, Treasury -
Erik Keptner,
Senior Vice President, Chief Marketing Officer -
Justin Mennen,
Senior Vice President, Chief Information Officer -
Andre Persaud,
Executive Vice President - Retail -
Susan K. Henderson,
Chief Communications Officer & Sr. VP -
Paul D. Gilbert,
Exec. VP, Gen. Counsel & Corp. Sec. -
Byron Purcell,
Sr. Director of Treasury Services & Investor Relations -
Brian T. Hoover,
Chief Accounting Officer & Sr. VP -
Michel Coutu,
Director -
James Donald,
Director -
Steven Bixler,
Chief Accounting Officer -
Bryan B Everett,
CHIEF OPERATING OFFICER -
Frank A Savage,
Director -
Michael N Regan,
Director -
Myrtle S Potter,
Director -
Joseph B Jr Anderson,
Director -
Castle Dedra Newman,
EVP -
David Jessick,
Director -
John T Standley,
Senior EVP & CAO -
David Abelman,
EVP -
Tony Montini,
EVP -
Darren W Karst,
EVP & CFO -
Kermit R Crawford,
President and COO -
Jessica Kazmaier,
EVP, Chief HR Officer -
James J Comitale,
EVP, General Counsel, Secy. -
Matt Schroeder,
EVP, Chief Financial Officer -
Derek S. Griffith,
Field EVP, Store Operations -
Benjamin Bulkley,
CEO EnvisionRXOptions -
Kenneth Martindale,
Senior Executive VP -
Andre Belzile,
Director -
Dennis Wood,
Director -
Philip G Satre,
Director -
Robert Gerald Miller,
Director -
Pierre Legault,
Senior EVP - CAO -
Equity Investors Iii Lpgree...,
-
Stuart M Sloan,
Director -
Douglas E Donley,
Senior VP and CAO -
Colin V Reed,
Director -
Robert Sari,
SVP AND GENERAL COUNSEL and -
Michael A Friedman,
Director -
Jonathan Ddanhakl John G So...,
-
George Golleher,
Director -
Robert J Easley,
Chief Operating Officer -
Mary F Sammons,
PRESIDENT & CEO -
Bruin Jerry Mark De,
EVP, Pharmacy -
Mark C Panzer,
SR. EVP - Store Operations -
Alfred Gleason,
Director -
Equity Investors Iii Lpgree...,
-
Kevin Twomey,
SVP & CHIEF ACCOUNTING OFFICER -
Robert A Mariano,
Director -
James P Mastrian,
SR.EVP.- Category Management -
Christopher Hall,
EVP and CFO -
Robert K Thompson,
EVP -
Robert Ivan Thompson,
EVP - Pharmacy -
Frank Vitrano,
Chief Admin. Officer & CFO -
Marc A Strassler,
EVP,General Counsel -
Coutu Group (Pjc) Inc. Jean,
10% owner -
Brian Fiala,
Executive VP, Operations -
Equity Investors Iii Lpgei ...,
-
John M Baumer,
Director -
Francois J Coutu,
Director -
Dan Robson,
President, EnvisionRXOptions -
Ray Smithberger,
SVP, Operations